Riskpilot← Back to searchSign inGet full accessDANDIAG A/S
A/SActiveCVR 20840382Baldersbuen 24Wholesale of pharmaceutical and medical goods · NACE 4646Est. 199844 employeeswww.dandiag.dk
Revenue 2025
DKK 22M
+3% vs 2024
EBITDA margin
-2.1%
+70% vs 2024
Equity ratio
30.7%
Financial strength
Net profit 2025
DKK -1M
+50% vs 2024
| Revenue | DKK 22M | +3% |
| EBITDA | DKK -459K | +70% |
| Net profit | DKK -1M | +50% |
| Total assets | DKK 23,8M | +18% |
| Equity | DKK 7,3M | -12% |
| Employees | 44 | — |
Legal name
DANDIAG A/S
CVR number
20840382
Legal form
Aktieselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
27. april 1998
Share capital
DKK 500.000
Employees
44 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren eller mindst to medlemmer af bestyrelsen.
Company purpose
Selskabets formål er handel med laboratorieudstyr og diagnostika, samt anden handel og dermed beslægtet virksomhed.
Address
Baldersbuen 24
Phone
+4543433057
Email
crn@dandiag.dk
Website
www.dandiag.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 9.691 | 12.528 | 12.122 | 13.076 | 14.778 | 16.632 | 17.024 | 17.289 | 25.282 | 31.145 | 25.420 | 26.265 | 21.379 | 21.974 |
| Staff expenses | -8.100 | -8.592 | -9.615 | -11.026 | -12.296 | -14.067 | -15.069 | -14.140 | -14.941 | -17.395 | -19.773 | -21.572 | -22.892 | -22.433 |
| EBITDA | 1.590 | 3.937 | 2.506 | 2.049 | 2.482 | 2.564 | 1.956 | 3.149 | 10.341 | 13.751 | 5.647 | 4.693 | -1.513 | -459 |
| Depreciation & amort. | -290 | -390 | -422 | -656 | -662 | -803 | -974 | -1.157 | -1.179 | -1.166 | -1.177 | -871 | -975 | -705 |
| EBIT | 1.300 | 3.547 | 2.085 | 1.393 | 1.820 | 1.762 | 982 | 1.992 | 9.162 | 12.585 | 4.469 | 3.822 | -2.488 | -1.164 |
| Net financials | -67 | -46 | -37 | 88 | -81 | -109 | -52 | -85 | 172 | 242 | -403 | 49 | -133 | -147 |
| Profit before tax | 1.233 | 3.501 | 2.048 | 1.481 | 1.739 | 1.652 | 930 | 1.906 | 9.334 | 12.827 | 4.066 | 3.870 | -2.621 | -1.310 |
| Tax | 326 | 869 | 521 | 351 | 393 | 366 | 206 | 422 | 2.054 | 2.823 | 897 | 855 | -575 | -287 |
| Net profit | 907 | 2.631 | 1.527 | 1.131 | 1.345 | 1.286 | 724 | 1.484 | 7.280 | 10.003 | 3.169 | 3.016 | -2.046 | -1.024 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 9.631 | 10.922 | 13.871 | 15.455 | 16.193 | 16.731 | 18.818 | 19.797 | 31.997 | 33.410 | 24.265 | 20.052 | 20.265 | 23.815 |
| Equity | 4.026 | 6.407 | 6.434 | 7.064 | 7.910 | 8.196 | 7.920 | 8.904 | 15.183 | 20.187 | 13.356 | 13.372 | 8.325 | 7.302 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9 | 0 | 15 | 15 | 16 | 23 | 680 |
| Short-term debt | 5.584 | 4.515 | 7.437 | 8.391 | 8.284 | 8.535 | 10.853 | 10.884 | 16.814 | 13.208 | 10.894 | 6.665 | 11.917 | 15.596 |
| Total debt | 5.584 | 4.515 | 7.437 | 8.391 | 8.284 | 8.535 | 10.853 | 10.893 | 16.814 | 13.223 | 10.909 | 6.681 | 11.940 | 16.276 |
EBITDA margin
-2.1%
This company
15.8%
Market median
-113% vs market
20122025
Equity ratio
30.7%
This company
38.2%
Market median
+20% vs market
20122025
Return on equity
-14.0%
This company
18.4%
Market median
-176% vs market
20122025
Net profit margin
-4.7%
This company
8.1%
Market median
-158% vs market
20122025
Asset turnover
0.92×
This company
1.12×
Market median
+18% vs market
20122025
Debt / equity
2.26×
This company
0.62×
Market median
-265% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
KS Management | Management | 1998 | — | — |
CR Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2021 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2007 | — | — | |
| Chairman | 2010 | — | — | |
| Board of Directors | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
NORDBJERG ApS | Company | 100.0% | 100.0% | 2000 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
NORDBJERG ApS
DANDIAG A/S Board members of DANDIAG A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Knud Simmelkær Jakobsen | Management | 0 companies |
| Charlotte Rugaard Nielsen | Chief Executive Officer | 0 companies |
| Henriette Mærsk Søndergaard | Board of Directors | 0 companies |
| Bente Nordbjerg Nielsen | Chairman | 0 companies |
| Bjarne Nordbjerg | Board of Directors | 0 companies |
| Bent Thomas Helvig Ludvigsen | Chairman | 0 companies |
| Nanna Nordbjerg Jensen | Board of Directors | 0 companies |